Inventor · disambiguated record
Brian E. Toki
Also filed as: TOKI BRIAN · TOKI BRIAN E
26 granted patents·22 pending applications·4,007 citations·filing 1999–2022
98Inventor score
Files withSEATTLE GENETICS INC26DORONINA SVETLANA O11ALLEY STEPHEN C2PSMA DEV COMPANY LLC2SEAGEN INC2
Top patents by PatentIndex Score
48 records- 0199US10808039B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2019·Granted Oct 20, 2020·18 cites·10 claims
- 0299US7994135B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Aug 9, 2011·164 cites·51 claims
- 0399US7964566B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 21, 2011·209 cites·60 claims
- 0499US7964567B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 21, 2011·134 cites·42 claims
- 0599US7851437B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2009·Granted Dec 14, 2010·163 cites·42 claims
- 0699US7829531B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2009·Granted Nov 9, 2010·199 cites·81 claims
- 0799US7745394B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2007·Granted Jun 29, 2010·193 cites·44 claims
- 0899US7659241B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSEATTLE GENETICS INC·Filed 2003·Granted Feb 9, 2010·442 cites·78 claims
- 0999US7553816B2p-amidobenzylethers in drug delivery agentsSEATTLE GENETICS INC·Filed 2002·Granted Jun 30, 2009·178 cites·51 claims
- 1099US7498298B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2004·Granted Mar 3, 2009·1.1k cites·22 claims
- 1199US7091186B2p-Amidobenzylethers in drug delivery agentsSEATTLE GENETICS INC·Filed 2001·Granted Aug 15, 2006·211 cites·38 claims
- 1299US6884869B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2001·Granted Apr 26, 2005·562 cites·2 claims
- 1398US8703714B2Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Granted Apr 22, 2014·59 cites·48 claims
- 1498US7098308B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2004·Granted Aug 29, 2006·101 cites·6 claims
- 1597US8557780B2Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Granted Oct 15, 2013·32 cites·15 claims
- 1697US7423116B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2006·Granted Sep 9, 2008·51 cites·24 claims
- 1796US8163551B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationALLEY STEPHEN C·Filed 2009·Granted Apr 24, 2012·48 cites·64 claims
- 1896US7256257B2Pentapeptide compounds and uses related theretoSEATTLE GENETICS INC·Filed 2002·Granted Aug 14, 2007·69 cites·52 claims
- 1995US10414826B2Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2017·Granted Sep 17, 2019·8 cites·20 claims
- 2093US9816069B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEATTLE GENETICS INC·Filed 2015·Granted Nov 14, 2017·6 cites·20 claims
- 2193US8993326B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEATTLE GENETICS INC·Filed 2013·Granted Mar 31, 2015·9 cites·20 claims
- 2291US8906376B2Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious diseaseSENTER PETER D·Filed 2010·Granted Dec 9, 2014·13 cites·20 claims
- 2391US8574907B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationALLEY STEPHEN C·Filed 2012·Granted Nov 5, 2013·19 cites·27 claims
- 2488US11319526B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEAGEN INC·Filed 2019·Granted May 3, 2022·2 cites·63 claims
- 2587US10443035B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEATTLE GENETICS INC·Filed 2017·Granted Oct 15, 2019·2 cites·12 claims
- 2680US2023055475A1Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEAGEN INC·Filed 2022·Application pending·0 cites
- 2778US2020347149A1Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2020·Application pending·0 cites
- 2869US2014220047A1Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2014·Application pending·0 cites
- 2967US2017000897A1Monomethylvaline compounds capable of conjugation to ligandsSEATTLE GENETICS INC·Filed 2016·Application pending·0 cites
- 3066US2008213289A1Recombinant anti-cd30 antibodies and uses thereofSEATTLE GENETICS INC·Filed 2008·Application pending·0 cites
- 3165US2012148608A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 3265US2012141509A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 3365US2012141510A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 3465US2012141508A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 3565US2012148610A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2012·Application pending·0 cites
- 3663US2012027784A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Application pending·0 cites
- 3763US2012034247A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Application pending·0 cites
- 3863US2012027783A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Application pending·0 cites
- 3963US2012034246A1Monomethylvaline compounds capable of conjugation to ligandsDORONINA SVETLANA O·Filed 2011·Application pending·0 cites
- 4059US2021023094A1Psma antibody-drug conjugatesPSMA DEV COMPANY LLC·Filed 2020·Application pending·0 cites
- 4157US2008317747A1Recombinant anti-cd30 antibodies and uses thereofSEATTLE GENETICS INC·Filed 2008·Application pending·0 cites
- 4254US2007258987A1Recombinant Anti-Cd30 Antibodies and Uses ThereofSEATTLE GENETICS INC·Filed 2004·Application pending·0 cites
- 4351US2005214310A1Melphalan prodrugsSEATTLE GENETICS INC·Filed 2005·Application pending·0 cites
- 4450US2007160617A1PSMA antibody-drug conjugatesPSMA DEV COMPANY LLC·Filed 2006·Application pending·0 cites
- 4549US2004018194A1Recombinant anti-CD30 antibodies and uses thereofFiled 2003·Application pending·0 cites
- 4645US2003083263A1Pentapeptide compounds and uses related theretoFiled 2001·Application pending·0 cites
- 4743US2005123536A1Treatment of immunological disorders using anti-dc30 antibodiesFiled 2002·Application pending·0 cites
- 4839US6943194B1Synthesis of phenstatin and prodrugs thereofUNIV ARIZONA STATE·Filed 1999·Granted Sep 13, 2005·4 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →